Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Bolt Threads
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of advanced silk production and textile fabrication technologies

Founded in 2009
Founded in

Company type Public Public (BSLK)
Company type

Industry Group materials & chemicals

Sector advanced materials

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Emeryville, CA Emeryville, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Lily Lin at on 07/24/2018

Edited by Cleantech Group on 10/01/2024

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
08/05/2021
Ginkgo Bioworks Ginkgo Bioworks
Bolt Threads partners with Ginkgo Bioworks to leverage their expertise in strain engineering to improve the sustainability, efficiency and cost effectiveness of Bolt's b-silk protein.
View source    
Confirmed by Ginkgo Bioworks
Channel Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

08/14/2024

IPO status

Listed

IPO Type

SPAC

Amount

$250M

Initial shares

Ticker symbol

BSLK

Exchange listed

NASDAQ

Prospectus URL

Prospectus

Source URL

Source

Description

Bolt Threads Enters $250 Million SPAC Agreement to Go Public on Nasdaq. The company will merge with Golden Arrow Merger Corp. (Nasdaq: GAMC). The concurrent financing deals are expected to provide at least $35 million of gross proceeds to the company, including fully committed common stock PIPE of up to $28 million at $10.00 per share anchored by Bolt Threads’ existing investors. The merger was successfully completed on August 14

Cancel Save
Add Investment
Date Investors Type Amount
09/01/2021 (0)
Post-money valuation of $1.1B
Previously unreported round
 Growth Equity $253,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font